In This Section
As director of Clinical Laboratories, Strategic Partnerships and Innovation at the Center for Applied Genomics, Dr. Santani oversees the clinical genomics program for the diagnosis of common and rare genetic disorders.
Dr. Santani serves as director of Clinical Laboratories, Strategic Partnerships and Innovation at the Center for Applied Genomics (CAG). In this role, she oversees the creation of a comprehensive, multi-disciplinary clinical genomics program for the diagnosis of common and rare genetic disorders.
Under her leadership, CAG is focused on forming strategic alliances with pharmaceutical companies, advancing gene discovery, developing comprehensive genetic tests, and developing innovative technologies and informatics tools.
Dr. Santani is an experienced leader in molecular diagnostics with years of experience in clinical testing, genomics, strategy, and laboratory administration. Her research focuses on leveraging advanced technology and informatics for the diagnosis of rare genetic disorders.
Education and Training
BS, University of Mumbai (Microbiology & Biochemistry), 1998
MSc, University of Aberdeen (Medical Molecular Genetics), 2001
PhD, University of Texas A&M (Genetics), 2004
Titles and Academic Titles
Director of Clinical Laboratories, Strategic Partnerships and Innovation, Center for Applied Genomics
Director, Division Genomic Diagnostics
Associate Professor of Clinical Pathology and Laboratory Medicine
American Society of Human Genetics, 2006-
American College of Medical Genetics, 2006-
National American Board of Medical Genetics, 2007-
Association for Molecular Pathology, 2013-
College of American Pathologists, 2014-
Noel Jorgensen Travel Fellowship, Plant and Animal Genome XII Conference, 2004
Fisher Medical Research Excellence Award, College of Veterinary Medicine, Texas A&M, 2005
Innovator of the Year Award - Philadelphia Business Journal, 2015
"Outstanding Contributions For The Prevention of Birth Defects," Beijing Genomics Institute and National Gene Bank of China, 2018